The deal ends the Sackler family's ownership of the company and bans them from ever selling opioids in the U.S. again.

The multi-billion-dollar payment is meant to resolve claims that the drugmaker's pain medication, OxyContin, caused an opioid crisis.

All 50 states, D.C., and four U.S. territories signed off on the multi-billion dollar settlement proposal with OxyContin maker Purdue Pharma in litigation over Purdue's alleged role in America's opioid addiction crisis.